You just read:

Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients

News provided by

Cannabics Pharmaceuticals Inc.

Feb 06, 2017, 11:00 ET